| Page 1813 | Kisaco Research
Interview with Bruce Daisley
 
Personalized Nutrition Innovation Summit 2018
26-27 Jun 2018
San Francisco, CA, USA
The Personalized Nutrition Innovation Summit is dedicated to the innovators & disruptors in nutrition. Bringing together industry leaders with emerging companies & start-ups to discuss the potential of this growing field on public health. Meet the start-ups redefining diet incorporating a wide range of analytics and technologies to provide insights into healthcare, and hear from global nutrition companies on how the technology revolution will impact the food industry & influence consumer trends.5 key benefits of attending:• Enabling collaboration through dedicated networking sessions• Hear from the disruptors like Habit• Gain insight from major nutrition companies like Kellogg to understand their drivers• Understand from STYR Labs about making better babies through personalized nutrition and AI• Recognize the major consumer trends reshaping nutritionFeaturing breakthrough technologies, including:• Microbiome analytics• Genomics• Biomarkers• Biosensors & wearables• AI & Big data• Retail & eCommerce
Visit Site
 
Microbiome Congress 2018
14-15 Nov 2018
London, UK
The Annual European Microbiome Congress by Kisaco Research has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require insight into the latest in microbiome research, clinical trials and collaborative partnerships.
Visit Site
 

Guillaume Crétenot

Vice President for Global Strategy, Ecosystem and Venture
Mars Petcare

At Mars Guillaume is Vice President for Global Strategy, Ecosystem and Venture. He develops and implements strategy to move from a FMCG business model to true Eco-system leader playing in products and services (vet services, pet owner services)

He also oversees the Leap Venture Studio & Academy

Prior to Mars, Guillaume was Principal in BCG

 

Read full bio

Guillaume Crétenot

Vice President for Global Strategy, Ecosystem and Venture
Mars Petcare

Guillaume Crétenot

Vice President for Global Strategy, Ecosystem and Venture
Mars Petcare

At Mars Guillaume is Vice President for Global Strategy, Ecosystem and Venture. He develops and implements strategy to move from a FMCG business model to true Eco-system leader playing in products and services (vet services, pet owner services)

He also oversees the Leap Venture Studio & Academy

Prior to Mars, Guillaume was Principal in BCG

 

Lux Research Personalised Nutrition Report
 

Emmanuelle Charpentier

Professor
Max Planck Institute for Infection Biology

Emmanuelle Charpentier

Professor
Max Planck Institute for Infection Biology

Emmanuelle Charpentier

Professor
Max Planck Institute for Infection Biology
 

Steve Rees

VP of Discovery Biology
AstraZeneca

Steve Rees is Vice-President of the Discovery Biology department at AstraZeneca with global responsibility for reagent generation, assay development and functional genomics.  Prior to this Steve led the Screening Sciences and Sample Management department at AstraZeneca with accountability  for Compound Management, the human tissue BioBank, Hit Discovery and Lead Optimisation biology support to preclinical discovery projects.  Prior to joining AstraZeneca, Steve worked at GlaxoSmithKline for 24 years in various roles.   Steve has led multiple international collaborations, has authored >65

Read full bio

Steve Rees

VP of Discovery Biology
AstraZeneca

Steve Rees

VP of Discovery Biology
AstraZeneca

Steve Rees is Vice-President of the Discovery Biology department at AstraZeneca with global responsibility for reagent generation, assay development and functional genomics.  Prior to this Steve led the Screening Sciences and Sample Management department at AstraZeneca with accountability  for Compound Management, the human tissue BioBank, Hit Discovery and Lead Optimisation biology support to preclinical discovery projects.  Prior to joining AstraZeneca, Steve worked at GlaxoSmithKline for 24 years in various roles.   Steve has led multiple international collaborations, has authored >65 scientific papers and has spoken at many international symposia.  He is currently Chairman of the European laboratory Research and Innovation Group, and a member of the Scientific Advisory Board for LifeArc, the Centre for Membrane Protein Receptor Research at the Universities of Birmingham and Nottingham and Axol Bioscience Ltd.

 

Richard Sherwood

Professor
Harvard University

My lab combines high-throughput genomic screening with machine learning to understand genome function in normal and diseased contexts. My work aims to advance precise genomic medicine and novel gene therapy applications.

Read full bio

Richard Sherwood

Professor
Harvard University

Richard Sherwood

Professor
Harvard University

My lab combines high-throughput genomic screening with machine learning to understand genome function in normal and diseased contexts. My work aims to advance precise genomic medicine and novel gene therapy applications.